Tobramycin + Fluorometholone in pharma franchise in Tripura

Tobramycin + Fluorometholone in PCD pharma franchise in Patna

Tobramycin + Fluorometholone in top pharma company in Amritsar

Tobramycin + Fluorometholone in pcd pharma supplier in Navi Mumbai

Tobramycin + Fluorometholone in phama franchise company in India
Tobramycin + Fluorometholone in phama distributor in Allahabad

Home/Products /tobramycin-0-point-3-w-v-fluorometholone-0-point-1-w-v-eye-ear-drop

About the Product

Description


Tobraxyle FML Eye Drop combines two active ingredients, Tobramycin and Fluorometholone, to provide effective treatment for bacterial eye infections while also reducing inflammation. Tobramycin, an aminoglycoside antibiotic, works by inhibiting bacterial protein synthesis, which stops bacterial growth and helps eliminate the infection. Fluorometholone, a corticosteroid, acts as an anti-inflammatory agent, reducing swelling, redness, and discomfort associated with eye infections.

This combination is particularly effective for treating conditions such as bacterial conjunctivitis, keratitis, and other ocular infections that involve both infection and inflammation. By addressing both the bacterial cause of the infection and the inflammatory response, Tobraxyle FML ensures faster recovery and relief of symptoms such as pain, swelling, and redness.

The inclusion of Fluorometholone in this formulation helps prevent the progression of inflammation, especially in cases where inflammation could lead to further complications, such as scarring or vision problems. Tobraxyle FML Eye Drop is typically used under the guidance of an ophthalmologist to ensure proper diagnosis and treatment. It is important to follow the prescribed dosage and duration to prevent the development of antibiotic resistance or unwanted side effects from corticosteroid use.

Common side effects include eye irritation, burning, stinging, redness, and blurred vision. If symptoms persist or worsen, consult a healthcare professional.

Tobraxyle FML Eye Drop is indicated for the treatment of bacterial eye infections associated with inflammation, including conjunctivitis and keratitis.

Do not use beyond the prescribed duration. Discard after 28 days of opening to prevent contamination.

Store the bottle in a cool, dry place away from direct sunlight. Keep the lid tightly closed and out of the reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Tobramycin 0.3% + Fluorometholone 0.1% Eye Drops in the PCD pharma franchise market?

Tobramycin 0.3% + Fluorometholone 0.1% Eye Drops is a combination ophthalmic anti-infective and anti-inflammatory medicine used for the treatment of bacterial eye infections with associated inflammation, such as conjunctivitis, blepharitis, keratitis, and post-operative eye inflammation. Tobramycin controls bacterial growth, while Fluorometholone (a mild corticosteroid) reduces redness, swelling, and inflammation. It is a strong ophthalmology combination segment product, widely used in eye hospitals, ophthalmologists’ clinics, and post-surgical eye care prescriptions.

Why should medical distributors include this eye drop in their range?

Medical distributors and wholesalers can benefit from high prescription demand from ophthalmologists and eye hospitals, especially for post-operative and infection-related eye conditions. Combination eye drops are widely prescribed, ensuring consistent repeat sales and strong retail + institutional demand.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for this product?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in ophthalmology, anti-infective, and steroid-eye combination segments with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this ophthalmic combination?

Wholesalers and medical agencies benefit from steady ophthalmology prescriptions, post-surgery demand, and continuous infection-inflammation treatment cycles, making it a stable and high-value pharmaceutical category when partnered with Cafoli Lifecare.

How can I become a distributor or franchise partner for Tobramycin + Fluorometholone Eye Drops?

Medical distributors, stockists, and pharma professionals interested in ophthalmology combination formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the eye care and specialty segment.